Form 4 for ESAB ESAB Corp
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001911320-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-02-27 | ESAB | Campion Michele | CHRO | M - OptEx | $47.34 | +7,196 | 18.4K | +64% | +$340.7K |
| D | 2026-03-02 | 2026-02-27 | ESAB | Campion Michele | CHRO | F - Tax | $122.63 | -4,300 | 14.1K | -23% | -$527.3K |
| DM | 2026-03-02 | 2026-02-27 | ESAB | Campion Michele | CHRO | S - Sale+OE | $122.63 | -5,096 | 11.2K | -31% | -$624.9K |
| DM | 2026-03-02 | 2026-02-26 | ESAB | Campion Michele | CHRO | A - Grant | $0.00 | +7,265 | 1,624 | New | $0 |
| D | 2026-03-02 | 2026-02-27 | ESAB | Campion Michele | CHRO | M - OptEx | $0.00 | -7,196 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2026-02-27 | M | A | 7,196 | $47.34 | 18,389 | D | — | — | |
| 2 | Common | Common stock, par value $0.001 | 2026-02-27 | F | D | 4,300 | $122.63 | 14,089 | D | — | — | (F2) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability. |
| 3 | Common | Common stock, par value $0.001 | 2026-02-27 | S | D | 2,200 | $122.63 | 11,193 | D | — | — | |
| 4 | Common | Common stock, par value $0.001 | 2026-02-27 | S | D | 2,896 | $122.63 | 11,193 | D | — | — | (F3) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.630 to $122.670, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2026-02-26 | A | A | 5,641 | $0.00 | 5,641 | D | $124.87 · 2027-03-01 to 2033-02-25 | 5,641 Common stock, par value $0.001 | (F4) These employee stock options vest and become exercisable in three equal, annual installments on the first day month following each of the first, second and third anniversaries of the date of grant. |
| 6 | Derivative | Restricted Stock Units | 2026-02-26 | A | A | 1,624 | $0.00 | 1,624 | D | — · 2027-03-01 to 2029-03-01 | 1,624 Common stock, par value $0.001 | (F5) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. (F6) These restricted stock units vest in three equal, annual installments on the first day of the month following each of the first, second and third anniversaries of the date of grant. |
| 7 | Derivative | Employee Stock Options (right to buy) | 2026-02-27 | M | D | 7,196 | $0.00 | 0 | D | $47.34 · 2023-05-12 to 2029-05-11 | 7,196 Common stock, par value $0.001 | (F7) These employee stock options vested and became exercisable in three equal, annual installments beginning on the first anniversary of the grant date. |